You just read:

OncoSec to Present Updated Clinical and Immune Biomarker Data from its Monotherapy and Combination Therapy Studies with ImmunoPulse® IL-12 at the 9th World Congress of Melanoma - A Joint Meeting with the Society for Melanoma Research

News provided by

OncoSec Medical Incorporated

Oct 12, 2017, 08:00 ET